Equity Overview
Price & Market Data
Price: $5.60
Daily Change: +$0.15 / 2.68%
Range: $5.00 - $5.60
Market Cap: $10,648,232
Volume: 5,058
Performance Metrics
1 Week: 39.02%
1 Month: 40.74%
3 Months: -5.00%
6 Months: 8.78%
1 Year: -42.83%
YTD: -23.69%
Details
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.